Research Studies
Facial Volume Loss
Study Specifics: For men and women, age 18-75. This trial uses an injectable filler for the treatment of mid-face volume loss.
Rosacea
Study Specifics: For men and women, age 18-65. This trial uses intradermal injections for the treatment of papulopustular rosacea.
Melasma
Study Specifics: For women, age 18-65. This trial uses a topical cream to reduce the visibility of Melasma (brown patches) on the face.
Cellulite
Study Specifics: A trial using an injectable for the treatment of mild to moderate buttock cellulite.
Cheek Wrinkles
Study Specifics: For men and women, age 18+. This trial is for the correction of fine lines on the cheeks.
Cosmetic Laser Dermatology Fellowship Program
Study Specifics: Sclero-2018-01, A comparison of the efficacy and safety of polidocanol foam
with 1:2 Polidocanol to air ratio VS. 1:4 ratio for the treatment of reticular veins of the lower
extremities
Cosmetic Laser Dermatology has been a part of many research studies.
Injectable Drug for Submental Body Contouring – 2024
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: 10xBio completes enrollment in Phase 2b clinical trial for its novel injectable drug, 10XB101, repurposing polidocanol for submental body contouring, aiming to provide enhanced efficacy and tolerability compared to current market alternatives.
Accure Needle Free – 2023
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: An Evaluation of the Efficacy and Tolerability of Two Alternate Treatment Protocols Using the Accure Laser
Accure – 2022
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: An Evaluation of the Effect of the Accure Laser on the Treatment of Moderate Inflammatory Acne Vulgaris 2
10xBio, LLC – 2022
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: 210-9451-203 A Multi-Center, Randomized, Double-Blind, Vehicle-Controlled Study Of The Safety And Efficacy Of Polidocanol (10xb-101) In Adult Subjects With Submental Fat
Allergan – 2022
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A single-centered randomized single-blinded clinical trial to evaluate efficacy and safety of sequential treatment of CoolsSulpting Elite with CoolTone vs. CoolSculpting Elite alone in treating the banana roll region
Biofrontera – 2022
Principal Investigator: Mitchel P. Goldman, MD
Clinical Trial: A randomized, double blind, vehicle-controlled, multicenter Phase II study to evaluate the safety and efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the treatment of moderate to severe Acne vulgaris in adults with photodynamic therapy (PDT)
Salix Pharmaceuticals – 2022
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: RE-ROS2002-2021: A phase IIa, multicenter, double blind, placebo controlled, randomized clinical trial to assess safety, efficacy and pharmacokinetics of Rifaximin Delayed-Release (Rifaximin-EIR) in patients with moderate-to-severe papulopustular rosacea
Allergan – 2022
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: CPH-301-201417: A randomized, subject- and evaluator-blinded, controlled, non-inferiority multicenter, parallel group comparison study to evaluate effectiveness and safety of saypha® VOLUME Lidocaine for midface augmentation in order to correct volume deficit
Caliway Biopharmaceuticals – 2022
Principal Investigator: Mitchel P. Goldman, MD
Clinical Trial: CBL-0201EFP: A Phase 2a, Open Label Study to Evaluate the Safety, Tolerability, and Efficacy of CBL-514 Injection for the Treatment of Edematous Fibrosclerotic Panniculopathy (EFP) cellulite
Cynosure – 2022
Principal Investigator: Mitchel P. Goldman, MD
Clinical Trial: A Single Center, Evaluator-Blinded, Split-Face, Randomized Clinical Trial of Combination Treatment with Fractional Picosecond 755nm Alexandrite Laser and Radiofrequency Microneedling for Atrophic Acne Scars
Biofrontera – 2021
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Safety and Efficacy of Photodynamic Therapy with Aminolaevulinic Acid 10% Topical Gel Activated by Red Light versus Aminolaevulinic Acid 20% Topical Solution Activated by Blue Light for the Treatment of Actinic Keratosis on the Extremities: A Multicenter, Randomized Observer-blind Study
Biorasi/ Alfasigma – 2021
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A phase IIa, multicenter, double blind, placebo controlled, randomized clinical trial to assess safety, efficacy, and pharmacokinetics of Rifaximin Delayed-Release (Rifaximin-EIR) in patients with moderate-to-severe papulopustular rosacea
CROMA-PHARMA GmbH – 2021
Principal Investigator: Mitchel P. Goldman, MD
Clinical Trial: CPH-301-201417 A randomized, subject- and evaluator-blinded, controlled, noninferiority multicenter, parallel group comparison study to evaluate effectiveness and safety of saypha® VOLUME Lidocaine for midface augmentation in order to correct volume deficit
Allergan Aesthetics, an AbbVie Company – 2021
Principal Investigator: Mitchel P. Goldman, MD
Clinical Trial: Protocol Number: MED-MA-PLS-0647CoolSculpting® Elite: Multi-Country Study to Evaluate Patient Satisfaction for Non-Invasive Fat Reduction in Abdomen, Flanks, Upper Arms, Inner Thighs, Outer Thighs and Submental Area (NuCOOL)
Concert Pharmaceuticals, Inc. – 2021
Principal Investigator: Mitchel P. Goldman, MD
Clinical Trial: CP543.3002. A double-blind, randomized, placebo-controlled study to evaluate the efficacy and safety of CTP-543 in adult patients with moderate to severe alopecia areata
Avita Medical – 2021
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: CTP009 A Prospective Multi-Arm Blinded Evaluator Within-Subject Randomized Controlled Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions
Galderma – 2021
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: RD.06.SPR.202685: A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Subjects with Prurigo Nodularis
Mindera Corporation – 2020
Principal Investigator: Mitchel P. Goldman, MD
Clinical Trial: An exploratory, multicenter, observational study to examine RNA biomarkers of psoriasis subjects through the application of the MiNDERA Microneedle Patch.
Pfizer – 2020
Principal Investigator: Mitchel P. Goldman, MD
Clinical Trial: A Phase 2, Randomized, Double-Blind, Vehicle-Controlled, Proof-of-Concept Study to Evaluate the Efficacy, Safety, and Local Tolerability of Crisaborole Ointment, 2%, in Adult Participants with Stasis Dermatitis without Active Skin Ulceration – site 1002
Trevi Therapeautics, Inc. – 2020
Principal Investigator: Mitchel P. Goldman, MD
Clinical Trial: Clinical Protocol No. TR11 entitled “A Phase 2b/3, Randomized, Double-blind, Placebo-controlled, 2-Arm, Efficacy, and Safety Study in Prurigo Nodularis with Nalbuphine ER tablets for Pruritus Relief through Itch Scratch Modulation (PRISM Study)
Galderma – 2020
Principal Investigator: Mitchel P. Goldman, MD
Clinical Trial: 43QM1901 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of QM1114-DP for the Treatment of Moderate to Severe Lateral Canthal Lines (READY–2)
Venthera – 2020
Principal Investigator: Mitchel P. Goldman, MD
Clinical Trial: An open-label, repeat-application, intra-subject, dose escalation (part 1) followed by a randomized, double-blind, placebo-controlled (part 2) trial of topical CT30 in subjects with venous, lymphatic or mixed malformations associated with PIK3CA or TEK genetic mutations
Galderma (2 Studies) – 2019
Principal Investigator: Mitchel P. Goldman, MD & Sabrina G. Fabi, MD
Clinical Study: 43USSA1806. Evaluate the safety of Sculptra Aesthetic when used with alternative reconstitution and injection procedures
ISDIN – 2019
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: ISD-FP-651-05-2019. Evaluation of an SPF50 sunscreen (651.69) in healthy volunteers to assess its anti-photoaging properties and photoprotection in daily practice. An open, single center, clinical study
Investigator Sponsored – 2019
Principal Investigator: Mitchel P. Goldman, MD & Kimberly Butterwick, MD
Clinical Study: Lipo Satisfaction Survey. The Evaluation of Skin Laxity and the Long Term Outcome Result after Liposuction.
Galderma – 2019
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Silkcheek-2018-01. Evaluate the efficacy and safety of Restylane® Silk microinjections when used in a grid-like injection pattern for the correction of fine lines to the cheeks
SkinCeuticals – 2019
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: SkinCeuticals-Dose. Evaluate the efficacy of D.O.S.E formulations in the treatment of melasma and cutaneous signs of aging.
Aclaris Therapeutics – 2019
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: SK-2018-01. Evaluate the Efficacy and tolerability of various modalities, microneedling and laser therapy to enhance the delivery of A-101 40% for the treatment of seborrheic keratoses.
Aclaris – 2019
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Comparison of Adjunctive Therapy with A 101 40% for the Treatment of Seborrheic Keratoses
Dyve Biosciences – 2019
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Protocol Number: DYV-604 Randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of topical tranexamic acid in a novel transdermal delivery system for improvement of melasma.
Solta – 2019
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Fraxel-2019-01. The safety and efficacy of combination treatment with a 1927 nm nonablative fractionated laser with and without topical tretinoin lotion for facial dyspigmentation and photodamage
Abbvie – 2019
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: M16-819. The safety and efficacy of risankizumab for the treatment of moderate to severe AD in adult and adolescent subjects.
AiViva – 2019
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: AIV001-R01-00. The Safety and Pharmacokinetics of Intradermally Administered AIV001 in Patients with Papulopustular Rosacea
SkinMedica / Allergan – 2018
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: SKM18-HULK-INJ, Open-Label, Randomized, multi-center study to evaluate the
efficacy and tolerability of two topical regimens in subjects with moderate to severe facial
photodamage who have received cosmetic injections
Sente – 2018
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: CO2 Laser Face/ SE17-MG-01, Sente, Inc. / Case Study to evaluate efficacy and
tolerability of Sente Dermal Repair Cream vs. Vehicle When use pre-& post ablative Laser
Biofrontera – 2018
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: ALA-BCC-CT013, A randomized, double-blind, vehicle-controlled multicenter phase III study to evaluate the safety and efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the treatment of superficial basal cell carcinoma (sBCC) with photodynamic therapy (PDT).
Aviva – 2018
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: AIV001-W01, A Randomized, Double-Blind, Vehicle-Controlled, Dose-Escalation Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Intradermally Administered AIV001 in the Healing of Incisional Wounds
Aclaris – 2018
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Protocol Number:A-101-WART-302 THWART 2:A phase 3 randomized, double-blind, vehicle-controlled, parallel group study of A-101 topical solution applied twice a week in subjects with common warts
Galderma – 2018
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A single center, prospective, open-label, clinical trial using micro-injections of transparent hyaluronic acid gel (Restylane® Silk) for rejuvenation of the aging cheek
Novella Clinical, Dermatology Division – 2018
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A Multicenter, Randomized, Double-Blinded, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of Topically Applied Xxxx) Gel, 5% and 15% in Subjects with Axillary Hyperhidrosis (the “Cardigan I and Cardigan II Studies”)
Solta – 2018
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: ThermageFLX-2018-001, Efficacy and Tolerability of New Generation Monopolar Radiofrequency for Lifting and Tightening Of the Face and Upper Neck
StrataMed – 2018
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A randomized, double-blinded, split-body, placebo-controlled trial to evaluate the efficacy and safety of fractional picosecond laser treatment followed by application of topical silicone gel for striae alba
10xBio, LLC – 2018
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: 210-9451-101:“A Study of the Safety, Tolerability, and Clinical Pharmacology of Subcutaneous 10XB-101 in Adult Subjects Undergoing Abdominoplasty”
Brickell Biotech, Inc. BBI-4000-CL-303 – 2018
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A Multicenter, Randomized, Open-Label, Phase 3 Long-term Safety Study of Topically Applied Sofpironium Bromide (BBL-4000) Gel, 5% and 15% in Subjects with Axillary Hyperhidrosis
Topix – 2018
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Double Blind, Side by Side comparison, using Replenix Pure Hydration HYALURONIC Acid Serum, along with Replenix Neckletage.
10xBio, LLC – 2018
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: 210-9451-101 Pilot:A Study of the Safety, Tolerability, and Clinical Pharmacology of Subcutaneous 10XB-101 in Adult Subjects Undergoing Abdominoplasty
Galderma – 2018
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A single center, prospective, randomized, sham controlled, double blind, split face trial using micro-injections of transparent hyaluronic acid gel (Restylane® Silk) for rejuvenation of the aging cheek
Allergan, Inc. #:IIT-2017-10121 – 2018
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A randomized, double-blind comparison trial of subcutaneous sodium Deoxycholate injections with or without triamcinolone for reduction of submental fat
Endo Pharmaceuticals, Inc. – 2018
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Edematous Fibrosclerotic Panniculopathy Study – EN3835-303
Cutanea and PRA Health Sciences Protocol #:CLS006-CO-PR-002 – 2017
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A Phase 3, Randomized, Double-Blind, Vehicle-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of CLS006 versus Vehicle in Subjects 2 years of age or older with Cutaneous Common Warts”
Cell ResearchCorp – 2017
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: CALECIM-2016-01, Improvement in the Appearance of Facial Wrinkles, Contour, Pigmentation and Overall Complexion with Red Deer Umbilical Extract
Ampersand Biopharmaceuticals, LLC – 2017
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: AMP-602- Randomized, double-blind, head-to-head, split-face study comparing tranexamic acid in a novel transdermal delivery system to hydroquinone for the treatment of melasma
Ilooda Co., Ltd. – 2017
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A prospective, single-center, investigator-blinded trial to evaluate the safety and efficacy of Secret Micro-Needle Fractional RF System® for the treatment of facial wrinkles
Investigator sponsored – 2017
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: PICO-VS-FRAX-2016- A randomized, split-face clinical trial of 532 nm picosecond laser with DLA versus 1,927 nm non-ablative fractional laser for the treatment of facial photodamage
Lutronic, Inc. – 2017
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Evaluation of the Lutronic Infini™ System for Reduction of Wrinkles, Lines and Texture on the Neck
Sienna Labs – 2017
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Clinical Investigation of a Topical Silver Particle Solution Followed by 810 nm
Allergan, Inc. – 2016
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: VOLUMA-006- A multicenter, single-blind, randomized, controlled study of the safety and effectiveness of JUVÉDERM VOLUMA® XC injectable gel for chin augmentation
Symbio, LLC – 2016
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study to Compare XXX to XXX and Both Active Treatments to a Vehicle Control in the Treatment of Inflammatory Lesions of Rosacea
Suneva Medical, Inc. – 2016
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: SUN-15-05 – Multiple Treatments of Bellafill® for Atrophic Acne Scar Correction in the Facial Cheek Area
Investigator sponsored – 2016
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: ScleroGlycerin-2016-0 – A Comparison of the Effect of Non-Chromated Glycerin Solution Formulated (2:1) with 1% Lidocaine with and without epinephrine used in Combination with Foam Polidocanol on Adverse Events and Efficacy Following Sclerotherapy for Reticular Veins and Telangiectasias of the Lower Extremities
Galderma – 2016
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: RS-2015-01 – A single center, prospective, randomized, sham controlled, double blind, split face trial using micro-injections of transparent hyaluronic acid gel (Restylane® Silk) for rejuvenation of the aging cheek
ProdermIQ – 2016
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: The Characterization of the Microbiome in Moderate to Severe Acne before and after Photodynamic Therapy
Endo Pharmaceuticals, Inc. – 2016
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: EN3835-202 – Collagenase clostridium histolyticum – A Phase 2, Open-Label Extension Study of EN3835 in the Treatment of Edematous Fibrosclerotic Panniculopathy
Allergan, Inc. – 2016
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: ATX-TRIAM-2016 – A randomized, double-blind comparison trial of subcutaneous sodium Deoxycholate injections with or without triamcinolone for reduction of submental fat
TR Therapeutics, Inc. – 2016
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: TR987-2016-SplitChest – TR-987 vs. placebo following fractionated CO2 laser resurfacing of the chest
TR Therapeutics, Inc. – 2016
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: TR987-InfraOrbital-2016 – TR-987 vs. placebo following infraorbital erbium-YAG ablative laser treatment
Foamix Pharmaceuticals, Inc. – 2016
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: FX2014-04 – A randomized, double-blind study to compare the efficacy, safety and long-term safety of topical administration of FMX-101 for 1 year in the treatment of moderate-to-severe acne vulgaris
Allergan, Inc. – 2016
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: VOLUMA-006- A multicenter, single-blind, randomized, controlled study of the safety and effectiveness of JUVÉDERM VOLUMA® XC injectable gel for chin augmentation
Merz North America, Inc. – 2016
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: RAD-ULT-Chest-2016- A Prospective, Randomized, Single-Center, Evaluator-Blinded Clinical Trial Evaluating the Safety, Efficacy, and Patient Satisfaction of Injectable Calcium Hydroxylapatite (Radiesse Plus®, Merz Aesthetic) in Combination with Micro-Focused Ultrasound for Rejuvination of the aging Chest
NuGene – 2016
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: NUGN-SPLT-2015-01-A Prospective, Split-Face trial for Reduction of Wrinkles
Thermi – 2016
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Thermi-Va-2015-01-A Single-Center, Non-Randomized Study to Assess Pre- and Post-Treatment Histopathologic Changes in Vulvovaginal Tissue Using a Transcutaneous Temperature Controlled Radiofrequency Device
Pomega, Inc. – 2016
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: POMEGA-2016-Topical Healing Regimen Following Fractionated CO2 Laser Resurfacing of the FACE
LEO Pharma – 2016
Principal Investigator: Mitchel P Goldman, MD
Clinical Study: LP0084-1195-Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Baldong Scalp including 12 month follow-up
Galderma – 2016
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: RS-2015-01-A Single Center, Prospective, Randomized, Sham Controlled, Double-Blind, Split Face Trial Using Micro-Injections of Transparent Hyaluronic Acid Gel (Restylane ® Silk) for Rejuvination of the Againg Cheek
Cynosure, Inc. – 2016
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: PicoSure-Infraorbital-2015-01 – A prospective study of the safety and efficacy of the 755 nm picosecond alexandrite laser for the treatment of infraorbital dark circles using a combination of two optics
Syneron, Inc. – 2016
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: PicoWay-Infraorbital-2015-01 – Treatment of infraorbital dark circles utilizing the novel dual wavelength picosecond Nd:YAG laser
Endo Pharmacueticals, Inc. – 2016
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: EN3835-201-Phase 2, Randomized, Double-Blind, Placebo-Controlled in the Treatment of Edematous Fibrosclerotic Panniculopathy
TR Therapeutics, Inc. – 2015
Principal Investigator: Mitchel P Goldman, MD
Clinical Study: TR987-2013-01 TR-987 vs. Placebo Following Fractionated CO2 Laser Resurfacing of the Chest
Kythera Biopharmaceuticals, Inc. – 2015
Principal Investigator: Mitchel P Goldman, MD
Clinical Study: ATX-101-15-40M CONTOUR – Condition of Submental Fullness and Treatment Outcomes Registry (A Registry of Submental Fullness, Treatment Options Administered, and Associated Outcomes)
LEO Pharma – 2015
Principal Investigator: Mitchel P Goldman, MD
Clinical Study: LP0105-1032 Efficacy and Safety of Ingenol Mebutate Gel in Field Treatment of Actinic Keratosis on Full Face, Balding Scalp or Approximately 250 cm2 on the Chest. An international, phase 3, randomized, parallel group, double-blind, vehicle-controlled trial.
Evolus, Inc. – 2015
Principal Investigator: Mitchel P Goldman, MD
Clinical Study: EVOLUS – CLIN006 A multi-center, open label, multiple dose, phase II trial to demonstrate the safety of DWP-450 in adult subjects for treatment of moderate-to-severe glabellar lines
Galderma Laboratories, L.P. – 2015
Principal Investigator: Mitchel P Goldman, MD
Clinical Study: GLI.04.SPR.US10321 A Prospective, Open-Label, Multicenter Study to Evaluate the Long-Term Safety of Sculptra® Aesthetic in Immuno-Competent Subjects Stratified by Fitzpatrick Skin Type I-VI
Zeltiq – 2015
Principal Investigator: Mitchel P Goldman, MD
Clinical Study: Coolsmooth-2015-01 Study of CoolSmooth PRO Applicator for Treatment of Pseudogynecomastia
Merz North America, Inc. – 2015
Principal Investigator: Mitchel P Goldman, MD
Clinical Study: P150998 Comparative Study of a Novel Neck and Décolleté Formulation for Improving the Appearance of Aged/Photodamaged Skin On the Neck and Chest Area
Suneva Medical, Inc. – 2015
Principal Investigator: Mitchel P Goldman, MD
Clinical Study: SUN-15-01 Evaluation of the In Vivo Effects of Various Laser, Light, or Ultrasound Modalities on Abdominal Skin Treated with Bellafill®, a Collagen and Polymethylmethacrylate Microsphere Dermal Filler Product
Seegpharm SA – 2015
Principal Investigator: Mitchel P Goldman, MD
Clinical Study: LO-17-3-2014A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing Metronidazole Gel, 1% to Metrogel® (Metronidazole Gel), 1% in the Treatment of Rosacea.
Neothetics – 2015
Principal Investigator: Mitchel P Goldman, MD
Clinical Study: LIPO-202-CL-23 A Double-Blind Extension Study to Evaluate the Post-Treatment Safety and Duration of Clinical Effect of LIPO-202 in Subjects Who Completed Either the LIPO-202-CL-18 or LIPO-202-CL-19 Study
Lithera, Inc. – 2015
Principal Investigator: Mitchel P Goldman, MD
Protocol #:LIPO-202-CL-18/19. A Multi-Center, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging
Baau/Galderma – 2014
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: 43QM1313;
LEO Pharma – 2014
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: PICATO-2013-01; A Pilot Prospective Clinical Trial to Evaluate the Efficacy and Safety of Large-Scaled Field-Directed Topical Therapy of Actinic Keratosis of the Chest with Ingenol Mebutate 0.015%
Merz – 2014
Principal Investigator: Mitchel P. Goldman, MD
Study: Clincial RAD-2010; A Single-Center Investigator-Initiated Evaluator-Blinded Randomized Bilateral-Comparison Pilot Study of Injectable Calcium Hydroxylapatite with and without Triamcinolone Acetate for the Treatment of Volume Loss to the Dorsum Areas of the Hands
Valeant Inc. – 2014
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A Prospective, Evaluator-Blinded Study of Post-Treatment Self-Massage vs. No Message Following Soft Tissue Augmentation with Injectable Poly-L-Lactic Acid
BAAU Therapeutics AB – 2014
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: 43QM1313; A Multicentre, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Three Doses of QM1114-DP in the Treatment of Moderate to Very Severe Glabellar Lines
LEO Pharma – 2014
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: LP0084-1013; Safety and Efficacy of Escalating Doses of Two 43204 Formulations Applied Once Daily for Two Consecutive Days on Full Face or Approximately 250 cm2 (40 in2) on the Chest in Subjects with Actinic Keratosis
ThermiAesthetics – 2014
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: THERMIRF-2014-01; An Investigator-Initiated Single-Center Study of the Safety and Efficacy of Treatments using the ThermiRF™ for Skin Laxity in the Inferior Aspect of the Upper Arms
SkinMedica – 2014
Principal Investigator: Mitchel P. Goldmn, MD
Clinical Study: SKM14-LYT-IPL-01; Open-label Study Assessing the Efficacy and Tolerability of a Series of Two Intense Pulse Light (IPL) Treatments with a Topical Multimodal Skin Brightener (Lytera® Skin Brightening Complex) in Subjects with Moderate to Severe Facial Hyperpigmentation
American Society of Dermatologic Surgery – 2013
Sub-Investigator: Mitchel P. Goldman, MD
Clinical Study: ScleroTC 2013-01; The Effect of Topical Corticosteroid Solution on Adverse Events Following Sclerotherapy for Reticular Veins and Telangiectasias of the Lower Extremities
MiMedx Group Inc. – 2013
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A Single- Center, Double-Blinded, Placebo-Controlled, Randomized, Split-Face Study to Evaluate the Efficacy of DHACM (Dehydrated Human Amnion Chorion Membrane) for Recovery After Fractionated Ablative CO2 Laser Resurfacing to the Face
PolyRemedy Inc. – 2013
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A Study Evaluating the Effect of Polyhdrate Mask as Adjunctive Agent in Microdermabrasion Treatment
PolyRemedy Inc. – 2013
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A Study Evaluating the Effect of Polyhydrate Lip and Crow’s Feet Masks as Adjunctive Agents in Cosmetic Facial Procedures
PolyRemedy Inc. – 2013
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A Study Evaluating the Effect of Polyhdrate Mask as an Adjunctive Agent in Cosmetic Facial Procedures
PolyRemedy Inc. – 2013
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A Study Evaluating the Effect of Polylaser Dry Mask in Combination with the Polyhydrate Mask as an Adjunctive Agent in Ablative or Fractional Ablative Laser Resurfacing
Allergan – 2013
Sub-Investigator: Mitchel P. Goldman, MD
Clinical Study: GMA-JUV13001; A Prospective, randomized, controlled, multi- center, study of the safety and effectiveness of Juvéderm® Ultra XC Injectable Gel versus Belotero Balance® for Perioral Lines
Christie, Inc. – 2013
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Evaluation of VeinViewer in Cosmetic Dermatology
Auxilium Inc. – 2013
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: AUX-CC-831; A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Effectiveness of Repeated Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy
Fibrocell, Inc. – 2013
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: FI-R-015:AN EXPLORATORY STUDY OF AZFICEL-T IN THE TREATMENT OF ABDOMINAL STRIAE
Sienna Labs – 2013
Principal Investigator: Mitchel P. Goldman, MD
Protocol: SL-002-2013-03; Study of a Topical Nanoparticle Followed by Treatment with an 810 nm Diode and 755nm Alexandrite Laser for Reducing Sebum Production in the Treatment of Acne:A Healthy Subjects Dosing Study
Cynosure, Inc. – 2013
Principal Investigator: Mitchel P. Goldman, MD
Protocol: PICO-2013-01; A Randomized, Split-Face, Double-Blind Clinical Pilot Study of Combination Picosecond Alexandrite Laser and Non-Hydroquinone Topical Therapy versus Topical Therapy Alone for the Treatment of Facial Melasma
Sapheon Inc. – 2013
Principal Investigator: Mitchel P. Goldman, MD
Protocol: CP-11101-01; Clinical Investigational Plan VenaSeal Sapheon Closure System vs. Radiofrequency Ablation for Incompetent Greater Saphenous Veins
BTL Industries, Inc. – 2013
Principal Investigator: Mitchel P. Goldman, MD
Protocol: BTL01-12ST; The Efficacy of a Treatment Protocol for the Tightening of Skin and Improvement in Appearance of Sagging Skin Using the Exilis Radiofrequency Device
Merz Aesthetics, Inc. – 2013
Principal Investigator: Mitchel P. Goldman, MD
Protocol: P110607; Evaluation of Radiesse® Dermal Filler for Hand Treatment
Revance Therapeutics, Inc. – 2013
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: RT001-CL023; An Open Label Multi-Center Study to Assess the Long-Term Safety of Repeat Administration of RT001 (Botulinum Toxin Type A) Topical Gel, for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults
Allergan, Inc. – 2013
Principal Investigator: Mitchel P. Goldman, MD
Protocol Number 1920240043:Bimatoprost for the Treatment of Eyebrow Hypotrichosis
Lithera, Inc. – 2013
Principal Investigator: Mitchel P. Goldman, MD
Protocol: LIPO-202-CL-16;A Multi-Center, Randomized, Double-Blinded, Placebo-Controlled, Dose-Ranging Study Evaluating the Safety and Efficacy of Salmeterol Xinafoate (SX) in the Aesthetic Treatment of Disproportionate Abdominal Bulging Due to Excess Subcutaneous Fat in Healthy, Non-Obese Patients
Uthera, Inc. – 2012
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: ULT-129; Prospective, Multi-Center, Pivotal Trial Evaluating the Safety and Effectiveness of the Ulthera® System for Improvement in Lines and Wrinkles of the Decolletage
Medicis Inc. – 2012
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A Parallel-group, Vehicle-controlled, Randomized, Double-blind Study of the Efficacy and Safety of Product 49778 and Product 10156 in Subjects with Seborrheic Dermatitis
Lutronic Inc. – 2012
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A randomized, split-face clinical trial of low-fluence Q-Switched Neodymium-Doped Yttrium Aluminum Garnet (1,064 nm) Laser versus low-fluence Ruby Laser (694 nm) for the treatment of facial melasma
Allergan (North America) – 2012
Sub-Investigator: Mitchel P. Goldman, MD
Protocol Number 192024-046:Bimatoprost in the Treatment of Eyelash Hypotrichosis
Allergan Inc. – 2012
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: GMA-BTXC-11-0004; Cross-Sectional Assessment and Chart Review of Long-Term Effectiveness, Safety and Patient Satisfaction of Facial Aesthetic Treatment with BOTOX®:A 10-Year International Experience
Syneron Inc. – 2012
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: DHF07021 Clinical Study to Evaluate the Performance of the ePrime for treatment of Striae Alba.
Lumenis, Ltd. – 2012
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: LUM-ABU-M22-ResurFX-12-01; Clinical Evaluation of M22 ResurFX 1565nm Handpiece
Sienna Labs, Inc. – 2012
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: SL-002-2012-01; A Randomized Blinded-Evaluator Investigator-Initiated Clinical Study to Evaluate the Safety and Efficacy of SL-002 used in Conjunction with Laser Hair Removal of the Axilla
Medicis, Inc. – 2012
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Randomized, Split-Face Study to Assess the Efficacy and safety of of AbobotulinumtoxinA (Dysport®) versus OnabotulinumtoxinA (Botox®) in the Treatment of Melomental folds (Depressor Anguli Oris)
Quinova, Inc. – 2011
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: NEOSALUS-2011-01; Investigation of a Novel Post Laser Resurfacing Skin Care Regimen
Kythera Biopharmaceuticals, Inc. – 2011
Principal Investigator: Mitchel P. Goldman, MD
Protocol: ATX-101-11-26; Multicenter, Open-Label Study of ATX-101 (Sodium Deoxycholate Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area
Pierre Fabre – Avene, Inc. – 2011
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Clinical Interest of Avene Thermal Spring Water in Dermatology
(Protocol #:Avene’-11)
Ulthera, Inc. – 2011
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: ULT-1XX:Evaluation of the Ulthera® System for Lifting and Tightening the Decollette
Solta Medical, Inc. – 2011
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Evaluate the efficacy of a single Thermage CPT treatment on the face and neck of male subjects.
Thermotek, Inc. – 2011
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Investigating the Efficacy of Artek Cold Air Cooling in minimizing pain in discomfort in Photodynamic Therapy
Medicis – 2011
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A Two-Center, Open-Label, Randomized, Split-Face Study to Assess the Efficacy of One Versus Three Intradermal Injection Sites of Dysport® in the Treatment of Lateral Periocular Rhytides
Sanofi-Aventis – 2011
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: POLY L 05403:A Clinical Study Evaluating the Added Benefit, Safety, and Patient Satisfaction of Injectable Poly-l-lacticacid, Sculptra, Combined with Intense Pulsed Light for Chest Rejuvenation
SkinMedica – 2011
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Efficacy and Tolerability of SkinMedica’sHyperpigmentation Kit versus Obagi NuDerm System for Facial Hyperpigmentation and Dermatoheliosis
SkinMedica – 2011
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A Split-Face Investigation of Topical Growth Factor Combined with a Monopolar Radiofrequency Device for Rejuvenation of the Aging Face
BTG International, Inc – 2011
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A randomized, multicenter study to evaluate the efficacy and safety of Varisolve Polidocanol Endovenous Microfoam (PEM) 0.5% or 1% compared to agitated saline and compared to Varisolve PEM 0.125% for the treatment of saphenofemoral junction (SFJ) incompetence
BTG International, Inc. – 2010
Principal Investigator: Mitchel P. Goldman, MD
Protocol: VAP.VV016; A Randomized, Blinded, Multicenter Study to Evaluate the Efficacy and Safety of Varisolve™ Polidocanol Endovenous Microfoam (PEM) 0.5% and 1% Compared to Vehicle for the Treatment of Saphenofemoral Junction (SFJ) Incompetence (VANISH-2)
Eclipse, Ltd. – 2010
Protocol: BJ-2010; A Side-by-Side Two-Hand Comparison Pilot Study of Fat Transplantation Harvested by Traditional Syringe Aspiration Followed by Centrifugation vs. Water Jet Aspiration
Allergan Medical – 2010
Protocol: VOLUMA-002; A Multicenter, Single-Blind, Randomized, “No-Treatment” Control, Study of the Safety and Effectiveness of JUVÉDERM® VOLUMA XC Injectable Gel for Cheek Augmentation to Correct Age-Related Volume Deficit in the Mid-Face
Mentor – 2010
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A Clinical Study Evaluating the Efficacy, Safety, and Patient Satisfaction of Injectable Hyaluronic Acid with 0.3% Lidocaine Hydrochloride, Prevelle Silk for Superficial, Vertical Perioral Lines and Superficial, Horizontal, Lateral Canthal Lines
Neocutis, Inc. – 2010
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Safety and Efficacy of PERLE and Melaplex for Hyperpigmentation Associated with Skin Aging
Biopelle – 2010
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: The Effects of a Filtrate of the Secretion of the Cryptomphalus Aspersa on Photoaged Skin
Syneron, Inc. – 2010
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A Side-by-Side Comparison of the Velashape II and a Cold Laser Device for the Treatment of Cellulite
Obagi Medical Products, Inc. – 2010
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Evaluation of Obagi Nu-Derm System in Individuals Undergoing Dermal Fillers and Toxin Injections to the Face
Human Med AG – 2010
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A Side-by-Side Two-Hand Comparison Pilot Study of Fat Transplantation Harvested by Traditional Syringe Aspiration Followed by Centrifugation Versus Water Jet Aspiration
Photocure ASA – 2010
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A Split-Face Study Investigating Allumera Combined with Multiple Laser and Light Sources for Photorejuvenation
Eleme Medical, Inc. – 2010
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A Single-Center Study to Demonstrate Improvement in Cellulite using the SmoothShapes System
Lithera, Inc. – 2010
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Lipo-102-CL-09:A Multi-center, Randomized, Double-Masked, Placebo-controlled, Dose-Ranging Study of the Safety and Efficacy of Subcutaneous Injections of Salmeterol Xinafoate (SX) and Fluticasone Propionate (FP) Compared with Placebo for the Reduction of Abdominal Subcutaneous Adiposity
Intendis, Inc. – 2010
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Combination Finacea gel and IPL therapy for mild to moderate rosacea
Bioform/Merz – 2010
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Treatment of Reticular and Telangiectatic Leg Veins:Double Blind Prospective Comparative Trial Between Aethoxyskerol and Hypertonic Saline
Eleme Medical, Inc. – 2009
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A Single-Center Study to Demonstrate Improvement in Lipoplasty Outcomes in Patients who Underwent SmoothShapes Treatments Before and After Lipoplasty
LifeWave, Inc. – 2009
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A multi-center, open-label study to determine the efficacy of a trans-dermal glutathione patch in the treatment of acne vulgaris
Syneron, Inc. – 2009
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Evaluation of the impact of fractional laser (Matrix IR) and fractional radiofrequency (Matrix RF) on the improvement of acne scars.
Crescendo Therapeutics, Inc. – 2009
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A Single-Center, Internally-controlled, Split-scar, Single-Blinded,Randomized Clinical Trial to Determine the Effects of the ScaRx™ Silicone Gel on Newly Formed Scars
New Star Lasers – 2009
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Evaluator-blinded, Randomized, Split-Lower Body Study to Assess the Safety and Efficacy of a Novel Subcutaneous 1320 nm Laser for the Treatment of Cellulite
Allergan, Inc. – 2009
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Comparative Efficacy and Safety of Tretinoin 0.025% Cream Used in Combination with Aczone Gel and Tretionin 0.025% Cream Monotherapy in the Treatment of Moderate to Severe Facial Acne Vulgaris
Galderma – 2008
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: GLI.04.SPR.US10100 Evaluator-blinded,Randomized, Split-Face Study to Assess the Safety and User Satisfaction with Three New Formulations of Pliagilis™ Cream
Obagi Medfical Products, Inc. – 2008
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: EMM-101 A Clinical Study Evaluating the Safety, Efficacy and Patient Satisfaction of Obagi Elastiderm Eye Cream Compared with Vehicle for the Treatment of Periocular Wrinkles and Upper Lid Crepeness in Patients having their Periocular Area (Crows Feet) Re-Treated with Botox® Cosmetic
Cynosure – 2007
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: CYN07-LIP-MC02 Clinical Evaluation of a 1064 nm and 1320 nm Sequentially Firing Laser Device with Accelerometer Safety Mechanism for Lipolysis
Galderma – 2007
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: GLI.04.SPR.US10081 Split-Face, Randomized, Open-Label Study of Sequential Treatment with Tri-Luma® Cream with Intense Pulsed Light vs. a Mild Inactive Control Cream with Intense Pulsed Light in Subjects with Melasma
Mentor – 2007
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: PT-03a Phase III Multicenter, Randomized, Double-Blind, Placebo-Controlled, Two-Arm, Single Dose Pivotal Trial to Demonstrate the Safety and Efficacy of PurTox for the Treatment of Glabellar Rhytids (Frown Lines)
Cynosure – 2007
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: (CYN07-AFF-GOLM01) Clinical Evaluation of the Affirm 1320-nm/1440-nm laser for the treatment of superficial wrinkles and textural abnormalities. Pigmentation, redness and localized tissue tightening of tissue exhibiting laxity in the face and neck.
Cynosure – 2007
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A Single Center, Randomized Prospective Clinical Study to Determine the Efficacy of the Cynergy Laser in the Treatment of Photoaging:Split Face Study
Cynosure – 2007
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Single-Center, Randomized, Phase IV Clinical Trial to Determine the Effects of Intense Pulsed Light with a 755 Filter for the Reduction of Facial Rhytides
Cynosure – 2007
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Clinical Evaluation of the Use of SmartLipo Compared to the Use of Traditional Liposuction for the Removal of Excess Fat
Allergan – 2007
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A Phase IV Multi-Center, Double-Blinded, Placebo Controlled Split-Face Study Evaluating the Efficacy of Vivite ™ Skin Care in the Treatment of Facial Elastosis
Obagi SkinCare – 2007
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: NMM-202 A Clinical Study Evaluating the Safety and Efficacy of Obagi Condition & Enhance System for Non-Surgical Procedures compared with a Placebo Regimen in Individuals Undergoing Intense Pulsed Light Source Therapy for the Treatment of Photo-Aging/Photo-Rejuvenation
Genzyme – 2007
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A subject and evaluator-blinded, randomized, multi-center study to evaluate the safety and effectiveness of injection with DGE injectable gel as compared to an FDA-approved dermal filler in subjects undergoing Cutaneous correction of nasolabial folds
Aesthera – 2007
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Treatment of inflammatory and comedonal acne with the use of the Aesthera PPx Intense Pulsed Light
Cynosure – 2007
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Affirm 1440-nm CAP laser for the treatment of photodamaged skin on the hands and arms
BioMed – 2007
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A Phase III, Randomized, double-blind placebo controlled study involving a novel gel-based patch for the improvement of the appearance of fine lines and wrinkles.
Cynosure – 2006
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Comparative study of a new Long-pulsed alexandrite and 1064nm Nd:YAG laser (Apogee Elite) for axillary hair removal compared with 810 nm diode laser
Allergan – 2006
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: The effect of Botox on intense pulsed light treatment:An investigator-initiated study
Spa MD – 2006
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Evaluation of the reduction in wrinkles and photodamage with the an antioxidant mixture, “Vitaphenol” compared to placebo cream
Johnson & Johnson – 2006
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A single-center, Placebo-controlled, double-blind, randomized clinical trial to determine the effects of the Biafine skin care system when utilized 4 weeks prior to PDT with the Lumenis 1 intense pulsed light source and blue light
Cynosure – 2006
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Effectiveness of the Cynergy 1064-595 laser in the treatment of photodamaged facial skin
Allergen – 2006
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: BTX 0607:A double-blind dose comparison of the safety and efficacy of BOTOX in the treatment of female subjects with moderate or severe glabellar rhytids
Bioform Medical – 2006
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Evaluation of radiesse vs restylane for the treatment of nasolabial folds
Steifel – 2006
Principal Investigator: Mitchel P. Goldman, MD and Michael Gold, MD
Clinical Study: MYX0601:Efficacy and safety of MimyX when used in combination with ALA-PDT therapy for the treatment of subjects with sun-damaged facial skin – Pilot study
Aesthera – 2006
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Evaluation of the Aesthera PPx System for the treatment of Fine Hair
Medi and Sigvaris – 2006
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Benefits of extended use of graduated compression stockings after sclerotherapy treatment of varicose and telangiectatic leg veins
Neocutis – 2005
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A Multi-Center, Placebo-Controlled, Randomized Clinical Trial of the Effects of Neocutis on Cutaneous rhytides
Niadyne, Inc. Protpcol:GG-ND05 – 2005
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A Multi-Center, Placebo-Controlled, Randomized Clinical Trial of the Effects of the Niadyne Skin Care System Utilized with Photorejuvenation with the Intense Pulsed Light.
Syneron – 2005
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A Randomized Evaluation of the VelaSmooth vs. Triactive in the Treatment of Cellulite on the thigh.
Tyrell, Inc. Protocol Number:TY-B-001 – 2005
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A Randomized, Controlled, Double-Blind Study of Localized Low Level Heat Treatment of Acne Blemishes using the Zeno® Device at Multiple Clinical Sites
– 2005
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A Multicenter Study to Validate Cosmetic Outcome Scales Used to Assess Irregular Skin Pigmentation and Wrinkling
Medicis MA-1400-02 – 2005
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A Prospective, Randomized, Comparative, Multi-Center Study of Sensitization of Restylene and Perlane and including Patient Diary Symptom Profile Assessments
Lumenis LUM-FACES – 0305-03 – 2005
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Non-Invasive, Non-Ablative Treatment for Wrinkles Reduction and Skin Tightening using High-Frequency Electricity (RF) Combined with Vacuum
Ispen Limited/Inamed – 2005
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Reloxin™ in the Re-Treatment of Glabellar Lines Following Open-Label Treatment
Medicis Pharnmaceuticals – 2005
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A Multicenter, Randomized Trial to Determine the Influence of 1320 nm Nd:YAG Laser (CoolTouch™), 1450 nm Diode Laser (Smoothbeam™), Radiofrequency Skin Tightening (Thermacool TC™) and Intense Pulsed Light (IPL) Therapy When Administered Immediately After Treatment with Hyaluronic Acid (Restylane®) for Tissue Augmentation of the Nasolabial Folds
Laserscope – 2004
Co-Investigator: Mitchel P. Goldman, MD
Clinical Study: Hair removal with the Laserscope Solis IPL System Multi-center Feasibility Study
Dusa Pharmaceuticals – 2004
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Effectiveness of 5 – aminoleukovonic acid with the Intense Pulsed Light in the Treatment of Photodamage
Pacific Bioscience Laboratories – 2004
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Pilot Study (Case Reports) of a Novel Skin Cleansing Device
Allergan – 2004
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A Randomized, Double-blinded Trial to Evaluate the Safety and Efficacy of Intradermal Botulinum Toxin A, , Botox® Combined with Topical Tazarotene, Avage® versus Intradermal Botulinum Toxin A, Botox® Alone in the Treatment of Lateral Periocular
Biogen-Idec and Dusa Pharmaceuticals – 2004
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A 12-Week Open-Label Study to Compare the Efficacy of a course of Alefacept (LFA-3/IgG1 Fusion Protein) versus Alefacept and Intense Pulsed Light (IPL) Treatment versus Alefacept and Photodynamic Therapy with Aminolevulinic Acid (ALA) and IPL Treatment in Subjects with Chronic Plaque Psoriasis.
Collagenx Pharmaceuticals, Inc. – 2004
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Determine the Effects of Doxycycline Monohydrate Modified Release Capsules Administered Once Daily for the Treatment of Rosacea
La Jolla SpaMD – 2004
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: An Open Trial Testing the Safety and Efficacy Spa MD Anti-Cellulite Cream™ for Cellulite of the Posterior and Lateral Thighs with and without Occlusion by a Bioceramic-coated Neoprine Garment
La Jolla SpaMD – 2004
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: An Open Trial Testing the Safety and Efficacy Spa MD Anti-Cellulite Cream™versus Placebo for Cellulite of the Posterior and Lateral Thighs with Occlusion by a Bioceramic-coated Neoprine Garment
Topix Pharmaceuticals – 2004
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Effectiveness of a Topical TGF ß Growth Factor with Vitamin C compared to TNS (SkinMedica) in the Treatment of Fine Lines on the Face.
STD Pharmaceuticals Ltd. – 2004
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Double-Blind Prospective Comparative Head-to-Head Study Between Aethoxyskerol™ and Fibrovein™ in the Treatment of Varicose and Telangiectatic Leg Veins
CollaGenix Pharmaceuticals Inc. – 2004
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Effectiveness of 5 – aminoleukovonic acid with and without Periostat®in the Treatment of Acne Vulgaris.
Lumenis – 2004
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Efficacy of the Lumenis One IPL and Vasculite Systems
Lumenis – 2004
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: The Efficacy of the Omega radiofrequency Device to Tighten Skin
Unilever – 2003
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Efficacy of Topical Treatment for Rosacea
Topix Pharmaceuticals – 2003
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Effectiveness of a Topical TGF ß Growth Factor with Vitamin C in the Treatment of Fine Lines on the Face.
Gentle Waves – 2003
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: The use of a Diode Array in the Treatment of Facial Photodamage
Dusa Pharmaceuticals – 2003
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Effectiveness of 5-aminoleukovonic acid with the Blu-U in the Treatment of Acne Vulgaris.
Deka-Cynosure – 2003
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Clinical Evaluation of a 1064 Long pulsed Nd:YAG, Alexandrite and Diode Laser in the treatment of unwanted hair.
Deka-Cynosure – 2003
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Clinical Evaluation of a Device for the Treatment of Cellulite:“TRIACTIVE”
New Star Lasers – 2002
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: The use of a 1320nm Endolumenal Laser to Close the Great Saphenous Vein
Lumenis – 2002
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A Prospective, Self-Controlled (versus Baseline), Multicenter Study to Determine the Effectiveness and Safety Through 0, 4 and 12 Weeks Following the Administration of 8 Treatments over 4 Weeks with the ClearLight™ PhotoClearing System in Teenagers and Young Adults for the Treatment of Acne Vulgaris
Lumenis – 2002
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: A Multicenter Evaluation of the Safety and Efficacy of ReLume Treatment for the Cosmetic Repigmentation of Mature Striae Distensae
New Star Lasers – 2002
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: Endolumenal 1320nm Laser Closure of the Greater Saphenous Vein
Allergan – 2002
Principal Investigator: Mitchel P. Goldman, MD
Clinical Study: An Evaluation of the Safety and Efficacy of Tazorac 0.1% Cream (QD) and Renova 0.05% Cream (QD) in the treatment of Subjects with Photodamaged Facial Skin
Abgenix, Inc. – 2002
Sub Investigator: Mitchel P. Goldman, M.D.
Clinical Study: “A Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Effects of Extended Treatment and Re-treatment of Patients with Plaque Psoriasis Enrolled in ABX-0204 Part II.”
Dermik Laboratories, Inc. – 2002
Sub Investigator: Mitchel P. Goldman, M.D.
Clinical Study: “An Open-Label, Multicenter, Phase IV Study of DL6021 for the Treatment of Mild and Moderate Acne Vulgaris “
Atrix Laboratories, Inc. – 2002
Sub Investigator: Mitchel P. Goldman, M.D.
Clinical Study: “A 12-Month, Multicenter, Open-Label, Non-Comparative Clinical Design Study of 5% Dapsone Topical Gel in Patients with Acne Vulgaris.”
Genentech, Inc. – 2002
Principal Investigator: Mitchel P. Goldman, M.D.
Clinical Study: “An Open-Label Multicenter Study to Evaluate the Efficacy and Safety of 1.0 mg/kg Subcutaneous Efalizumab Followed by Efalizumab Taper in Adults with Plaque Psoriasis Previously Enrolled in Study ACD2390g.”
Genentech, Inc. – 2002
Principal Investigator: Mitchel P. Goldman, M.D.
Clinical Study: “A Phase IIIb, Randomized, Double-Blind, Parallel-Group, Placebo- Controlled, Multicenter Study to Evaluate the Efficacy and Safety of 1.0 mg/kg Subcutaneously Administered Efalizumab in Adults with Moderate to Severe Plaque Psoriasis.”
Galderma R&D, Inc. – 2002
Principal Investigator: Mitchel P. Goldman, M.D.
Clinical Study: “Evaluation of the Efficacy and Safety of Twice Daily Application of Calcitrol3 µg/g Ointment and its Vehicle in the Treatment of Chronic Plaque Psoriasis.”
Ortec International, Inc. – 2002
Principal Investigator: Mitchel P. Goldman, M.D.
Clinical Study: “A Pivotal Study to Evaluate the Safety and Efficacy of Cryopreserved Bilayered Cellular Matrix (CYRO-OrCel™) for the Treatment of Venous Ulcers.”
Provensis – 2002
Principal Investigator: Mitchel P. Goldman, M.D.
Clinical Study: “A Multicenter, Randomized, Phase III Study to Evaluate the Safety, Efficacy and Patient Acceptability of the Varisolve technique Using 1% Polidocanol Microfoam.”
Neutrogena – 2001
Principal Investigator: Mitchel P. Goldman, M.D.
Clinical Study: “Compatibility Study for Application of Daily SPF 30 Moisturizer Following Treatment with Glycolic Peel, Microdermabrasion or Non-Invasive Laser”
3M Pharmaceuticals – 2001
Sub Investigator: Mitchel P. Goldman, M.D.
Clinical Study: “Vehicle-Controlled, Double-Blind Study to Assess the Safety and Efficacy of Imiquimod 5% Cream Applied Once Daily 2 Days per Week for the Treatment of Actinic Keratoses of the Head.”
GlaxoSmithKline – 2001
Sub Investigator: Mitchel P. Goldman, M.D.
Clinical Study: “A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Efficacy of Three Dose Levels of Rosiglitazone Maleate in the Treatment of Moderate to Severe Plaque Psoriasis.”
Photogen, Ing. – 2001
Sub Investigator: Mitchel P. Goldman, M.D.
Clinical Study: “A Phase I Safety Study of Topical PH-10 Solution and Laser Light for the Treatment of Plaque Psoriasis.”
Abgenix, Inc. – 2001
Sub Investigator: Mitchel P. Goldman, M.D.
Clinical Study: “A Two-Part, Multi-Center, Randomized, Double-Blind Placebo- Controlled, Multiple Dose Clinical Trial of ABX-IL8 in Patients with Moderate to Severe Plaque Psoriasis”
SkinMedica, Inc. – 2001
Sub Investigator: Mitchel P. Goldman, M.D.
Clinical Study: “A Marketing Study for a Multi-Center, Double-Blind, Vehicle- Controlled Split Face Trial to Evaluate Treatment of Photodamage Using Tissue Cytokines in a Topical Formulation Compared to its Vehicle”
Electro-Optical Sciences, Inc. – 2001
Principal Investigator: Mitchel P. Goldman, M.D.
Clinical Study: “Patient Examination with MelaFind System Developed by Electro-Optical Sciences, Inc. (EOS)”
Dermatology Associates of San Diego County, Inc. – 2001
Principal Investigator: Mitchel P. Goldman, M.D.
Clinical Study: “Hair Removal of the Bikini Area Using the CoolGlide vs. CoolTouch Varia”
Ortec International CRO:Clintrials – 2001
Principal Investigator: Mitchel P. Goldman, M.D.
Clinical Study: “A Pivotal Randomized Study to Examine the Safety and Efficacy of a Collagen Matrix Containing Allograft Cells for the Treatment of Venous Ulcers”
SkinMedica – 2001
Co-Investigator: Mitchel P. Goldman, M.D.
Clinical Study: “Precision Peel vs. Glycolic Acid 30% for Treatment of Melasma”
SkinMedica – 2001
Co-Investigator: Mitchel P. Goldman, M.D.
Clinical Study: “Precision Peel vs. Glycolic Acid 30% for the Treatment of Acne”
Zars, Inc. – 2001
Co-Investigator: Mitchel P. Goldman, M.D.
Clinical Study: “A Randomized Comparison of the S-Caine Peel to Emla Applied Prior to Hair Removal Treatment”
Clinicon Corporation – 2000
Principal Investigator: Mitchel P. Goldman, M.D.
Clinical Study: A comparison of clinical outcomes using the Sureblade™Diamond Laserknife versus cold steel and electrocautery in patients undergoing excisional surgery.”
Laser Photonics – 2000
Principal Investigator: Mitchel P. Goldman, M.D.
“Gathering information about psoriasis treatment with the laser Photonics AL 7000 Excimer Laser Phototherapy System’
Ferndale Laboratories, Inc. – Mar 2000
Principal Investigator: Mitchel P. Goldman, M.D.
Clinical Study: A multicenter clinical study to evaluate the efficacy of 4% Liposomal Lidocaine as compared to EMLA Cream for pain reduction during laser treatment.
Genentech – Mar 2000
Principal Investigator: Mitchel P. Goldman, M.D.
Clinical Study: A phase III, randomized, double-blind, parallel-group, placebo- controlled, multicenter, multiple dose study to evaluate the efficacy and safety of subcutaneously administered anti-CD11a in adults with moderate to severe plaque psoriasis who are candidates for systemic therapy.
SkinMedica – Product Studies – 1999/2000
Principal Investigators: Richard Fitzpatrick and Mitchel P. Goldman
Vitamin C Complex vs Skinceuticals Vitamin C Serum (12/1999) “”A Double-Blind, Randomized, Placebo-Controlled Split-Face Study Comparing SkinMedica Vitamin C Complex vs. Placebo.Protocol SM-REF99-C.
Retinol Complex vs Placebo (3/2000)
A Double-Blind, Randomized, Placebo-Controlled Split-Face Study Comparing Protocol SM-REF99-RCBX.
Allergan, Inc. – 1999
Principal Investigator: Richard Fitzpatrick and Mitchel P. Goldman
A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Group Study of the Safety and Efficacy of AGN 194310 Ointment 0.01% Applied Twice Daily for 4 Weeks in the Prevention of Cheilitis Associated with Oral Isotretinoin Treatment in Severe Nodular Acne Patients.
Merz Pharmaceuticals – Oct 1999
Principal Investigator: Mitchel P. Goldman, M.D.
Clinical Study: Evaluation of the safety and efficacy of Mederma in the reduction in the severity of post surgical hypertrophic scars.
Merck & Co., Inc. – Sept 1999
Principal Investigator: Mitchel P. Goldman, M.D.
Clinical Study: A double-blind, randomized, placebo-controlled, multi-center comparison/combination study with L-762943 and oral minocycline to determine their effects in young men with moderate to severe acne.
Certified Scientific, Inc. – Aug 1999
Merck & Co., Inc.
Principal Investigator: Mitchel P. Goldman, M.D.
Clinical Study: A multiple-rater validation study to assess reliability of lesion counting in moderate and severe acne patients.
Allergan – June 1999
Principal Investigator: Mitchel P. Goldman, M.D.
Clinical Study: A multicenter, open label study of the safety and effectiveness of Botox (Botulinum toxini, type A) Purified Neurotoxin Complex in subjects with glabellar lines.
Janssen/McNeil – Feb 1999
Principal Investigator: Mitchel P. Goldman, M.D.
Clinical Study: “A Double-Blind, Placebo-Controlled Study of Ketoconazole 2% Shampoo in the Treatment of Pityriasis Versicolor in Adolescents”.
Allergan – Feb 1999
Principal Investigator: Mitchel P. Goldman, M.D.
Clinical Study: “A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel Study of the Safety and Efficacy of Botox® (Botulinum Toxin, Type A) Purified Neurotoxin Complex in Subjects with Glabellar Lines”.
Johnson & Johnson – Feb 1999
Principal Investigator: Mitchel P. Goldman, M.D.
Clinical Study: “The Evaluation of an Instrument to Detect Biomechanical Changes in the Skin Following Application of Amine Complex Face Lift Moisturizer”.
New Star Lasers, Inc. Rosemont, CA – 1999
Principal Investigator: Mitchel P. Goldman, MD
“Phase III Clinical Investigation of the Laser Aesthetics, Inc. Model 130 Cool Touch® 6-Watt Nd:YAG Laser System for Treatment of Facial Rhytides”, Laser Aesthetic, Auburn, CA – device cleared for treatment of peri-ocular actinic rhytids.
New Star Lasers, Inc. Rosemont, CA – 1999
Principal Investigator: Mitchel P. Goldman, MD
“Phase II Efficacy Study of Long-pulsed, Model 140 Cool Touch® 6-Watt Nd:YAG Laser System dynamically cooled Nd:YAG Laser for Leg Telangiectasias”, Laser Aesthetics, Auburn, CA – Device cleared for telangiectasias
ESC/Luxor Corporation – 1998
Co-Investigator: Mitchel P. Goldman, M.D.
Clinical Study: “”Laser Skin Resurfacing, with the Derma-K Laser System for Treatment of Aged or Photodamaged Skin””
Merz Pharmaceuticals – Dec 1998
Principal Investigator: Mitchel P. Goldman, M.D.
Clinical Study: “Evaluation of the Safety and Efficacy of Mederma Compared to Vehicle in Reduction of the Severity and Duration of Post-Operative Erythema Due to Laser Resurfacing”
ESC Medical Systems, Inc. – Nov 1998
Co-Investigator: Mitchel P. Goldman, M.D.
Clinical Study: “Use of 755nm Cut-Off Filter in Epilation with Epilite”
Allergan Pharmaceuticals, Inc. – Sept 1998
Principal Investigator: Mitchel P. Goldman
Study: Clinial “Evaluation of the Safety & Efficacy of Azelex®(AzelaicAcid 20% Cream) Compared to Vehicle in the Reduction of the Severity and Duration of Post-InflammatoryHyperpigmentation Due to Laser Resurfacing in Subjects with a Skin Phototype of III or IV”
Johnson & Johnson – Aug 1998
Principal Investigator: Mitchel P. Goldman, M.D.
Experimental Study: “Laser Resurfacing:Evaluation of Epithelial Regeneration in a Porcine Model”
Allergan – July 1998
Sub-Investigator: Mitchel P. Goldman, M.D.
Clinical Study: “Multicenter, Double-Blind, Randomized, Vehicle-Controlled Study of the Safety and Efficacy of 0.05T and 0.1% Tazarotene Creams Applied Once Daily for 12 Weeks with a 12-Week Follow-Up in the Treatment of Plaque Psoriasis”
Mylan Pharmaceuticals – May 1998
Sub-Investigator: Mitchel P. Goldman, M.D.
Clinical Study: “A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel Group Evaluation of the Efficacy and Safety of Sertaconazole 2% Cream in Patients with Interdigital Tinea Pedis”.
Rofil Medical – Apr 1998
Sub-Investigator: Mitchel P. Goldman, M.D.
Clinical Study: “For the Evaluation of Artecoll, PMMA Microsphperes in 3.5% Collagen for Soft Tissue Augmentation””.
ESC Medical, Inc. – 1998-1999
Principal Investigator: Mitchel P. Goldman, M.D.
“Phase III Multi-Center, Efficacy Study of Vasculight® Long-pulsed Nd:YAG Laser for Leg Telangiectasias,” ESC/Sharplan, Needham, MA
Johnson & Johnson/Neutrogena – Oct 1997
Principal Investigator: Mitchel P. Goldman, M.D.
Clinical Study: “The Effect of an Integrative Wound Management Regimen for Skin Following Facial Resurfacing Procedures”.
Circ-Aid Medical Products – Mar 1997
Principal Investigator: Mitchel P. Goldman, M.D.
Clinical Study: “A Multicenter, Prospective, Randomized, Parallel Group Study to Evaluate the Costs of Treating Venous Ulcer Patients with Unna’s Boot or Circ-Aid® Thera-Boot™”.(#CA961-rev.11/5/96)
ESC Medical Systems, Inc. – Dec 1996
Co-Investigator: Mitchel P. Goldman, M.D.
Clinical Study: “Skin Resurfacing Using the ESC Derma™ 20 Laser System”. (#PB6002007)
Johnson & Johnson Consumer Products – Dec 1996
Principal Investigator: Mitchel P. Goldman, M.D.
Clinical Study: “The Effects of Novel Dressing Therapies on the Healing of Partial Thickness Wounds”.
ESC Medical Systems – Oct 1996
Co-Investigator: Mitchel P. Goldman, M.D.
Clinical Study: “ESC Epilight™ HR System for Hair Removal”. (PD02A/95)
Jobst/Beiersdorf Company – Apr 1996
Principal Investigator: Mitchel P. Goldman, M.D.
Clinical Study: “The Effect of External Compression on Venous Hemo Dynamics”.
Bristol-Myers Squibb – Feb 1996
Principal Investigator: Mitchel P. Goldman MD
Clinical Study: “A Multi-Center, Double Blind, Parallel Group Efficacy and Safety Comparison of Ifetroban and Placebo, in Patients with Venous Leg Ulcers.-9 month Extension”
Coherent, Inc. – 1995
Principal Investigator: Richard E. Fitzpatrick, M.D.
Co-Investigators: Mitchel P. Goldman, Roy G. Geronemus, M.D., Joop M. Grevelink, M.D., Suzanne L. Kilmer, M.D., Gary Lask, M.D., Paul C, Levins, M.D., David H. McDaniel, M.D. Resurfacing Facial Acne Scars Using the UltraPulse CO2 Laser
Burroughs-Wellcome – 1995
Principal Investigator: Mitchel P. Goldman MD
Clinical Study: “”A Double Blind, Multicenter Study Comparing Valacyclovir with Famciclovir for the Treatment of Uncomplicated Herpes Zoster in Immunocompetent Patients 50 Years of Age and Older.””(Protocol 310-123)
Lidak Pharmaceuticals – 1995
Principal Investigator: Mitchel P. Goldman MD
Clinical Study: “”A Clinic Initiated Double-Blind, Placebo Controlled, Multicenter Study to Assess the Safety and Efficacy of Topical N-Docosanol 10% Cream (Lidakol) in Patients with Early Stage Episodes of Acute, Recurrent Herpes Labialis””.
Matrix Pharmaceuticals, Inc. – Mar 1995
Principal Investigator: Mitchel P. Goldman MD
Clinical Study: “”A Randomized, Controlled Study to Evaluate the Contributions of Components in Fluorouracil/Epinephrine (5-FU/epi) Injectable Gel in Patients with Basal Cell Carcinoma””
Bristol-Myers Squibb – Feb 1995
Principal Investigator: Mitchel P. Goldman MD
Clinical Study: “”A Multi-Center, Double-Blind, Parallel Group Efficacy and Safety Comparison of Ifetroban and Placebo in Patients with Venous Leg Ulcers””
Coherent – Feb 1995
Co-Investigator: Mitchel P. Goldman MD
Study: “”Resurfacing of fine to Deep Facial Wrinkles Using the Ultrapulse CO2 Laser””
Penederm – Jul 1994
Principal Investigator: Mitchel P. Goldman MD
Clinical Study: “”A Multicentered, Double-Blind Study to Evaluate Butenafine HCL 1% Cream and Vehicle in the Treatment of Tinea Cruris”” (Protocol #PDC 010-005)
Sandoz – Jul 1994
Principal Investigator: Co-Mitchel P. Goldman MD
Clinical Study: “”A Randomized, Double-Blind, Placebo Controlled, Multicenter Study of the Efficacy and Safety of Lamisil (Terbinafine) 1% Solution – Topical, Compared to Vehicle BID for One Week in Subjects with Pityriasis Versicolor”” (Protocol #SFF 353-E-OO).
Sandoz – Jul 1994
Principal Investigator: Co-Mitchel P. Goldman MD
Clinical Study: “”A Randomized, Double-Blind, Placebo Controlled, Multicenter Study of the Efficacy and Safety of Lamisil (Terbinafine) 1% Solution – Topical, Compared to Vehicle BID for One Week in Subjects with Interdigital Type Tinea Pedis (Athletes Foot)””(Protocol #SFF 351-E-OO).
Genta, Inc – May 1994
Principal Investigator: Mitchel P. Goldman MD
Clinical Study: “”A Pilot Study to Evaluate the Safety and Efficacy of SCY-ER in Patients Affected by Moderate to Severe Nodular Acne Vulgaris”” (Protocol #GEN-9404101)
American College of Phlebology Research Grant – Feb 1994
Principal Investigator: Mitchel P. Goldman MD and Pauline Raymond-Martimbeau MD
Experimental Study: Clinical and Histologic Effects of Intravascular Injections of American Iodine versus Sodium Iodide in the Rabbit Ear Vein Model
Hyal Pharmaceutical Corp. – May 1993
Principal Investigator: Mitchel P. Goldman MD
Clinical Study: “”Open-Label Evaluation of the Safety and Efficacy of Topical DHA Gel (Diclofenac/Hyaluronic Acid) in the Treatment of Superficial Basal Cell Carcinoma””
Smith Kline Beecham – Apr 1993
Co-Investigator: Mitchel P. Goldman MD
Clinical Study: “”A Prospective, Randomized, Double-Blind, Multicenter, Patient-Initiated Study to Compare the Efficacy of Topical 1% Penciclovir Cream with Placebo in Patients with Recurrent Herpes Simplex Labialis Infection””
Amgen, Inc. – Apr 1993
Principal Investigator: Mitchel P. Goldman MD
Experimental Study: Phase I/II study to determine the safety and biological activity of R-met Hu IL-2 in severe plaque psoriasis
Candela Laser Corporation – Apr 1993
Principal Investigator: Co-Mitchel P. Goldman MD, Richard E. Fitzpatrick MD, Nancy M. Satur MD, Kenny R. Malott MD
Clinical Study: Treatment of Yellow, Orange, Red, Violet/Purple, Tan and Flesh colored Tattoos with Candela’s 510nm Pulsed Dye Laser””
Kreussler Pharmaceuticals, GbH – Jan 1993
Co-Directors: J. Leonel Villavicencio MD, Mitchel Goldman MD, John Pheifer, MD, John Cranley MD
Clinical Phase II Study: Comparison of Relative Efficacy of Polidocanol and Sodium Tetradecyl Sulfate. FDA IND # 35139
Telios Pharmaceutical Inc. – Jan 1993
Principal Investigator: Mitchel P. Goldman, M.D.
Clinical Study: Randomized multi center trial comparing the safety and efficacy of Telio-DermR with a synthesized dressing vs. saline control with a synthesized dressing in patients with venous leg ulcers (protocol TD-14, post Phase III Study)
Advanced Tissue Sciences, La Jolla, CA – 1993-1994
Principal Investigator: Mitchel P. Goldman, M.D.
Clinical Study: DG 02 02 1292, “”A Multicenter, Single blind Clinical Trial to Determine the Efficacy of DermagraftTM, A Living Dermal Replacement, in the Treatment of Chronic Venous Insufficiency Ulcers,” Phase III study
Candela Laser Corporation – Dec 1992
Principal Investigator: Co-Mitchel P. Goldman MD, Richard E. Fitzpatrick MD, Nancy M. Satur MD, Kenny R. Malott MD
Clinical Study: “”Treatment of Blue, Green, Brown and Reddish-Brown Tattoos with Candela’s PLTL-1 Laser System Q-switched Alexandrite Laser.””
ESC – Energy Systems Corporation, LTD – Nov 1992
Principal Investigator: Mitchel P. Goldman, MD, Richard E. Fitzpatrick, MD
Clinical Study: Clinical Effects of the ESC Vascular Lesion Pulsed Light Source on Human Vascular Lesions.
ESC – Energy Systems Corporation, LTD – Sep 1992
Principal Investigator: Mitchel P. Goldman MD
Experimental Study: Clinical and Histologic Effects of the ESC vascular lesion pulsed light source on rabbit ear vein.
Candela Laser Corporation – Sep 1992
Principal Investigator: Co-Mitchel P. Goldman MD, Richard E. Fitzpatrick MD
Clinical Study: “”Treatment of Tattoos with Candela’s Q-switched Alexandrite Laser””
Rhone-Poulenc Rorer – Aug 1992
Co-Investigator: Mitchel P. Goldman MD
Experimental Study: Randomized, comparative, multi-center study of RP64206 (Sparfloxacin) vs. Ciprofloxacin in the treatment of community acquired, complicated skin and skin structure infection.
Smith Kline Beecham Pharmaceutical Company – Jul 1992
Co-Investigator: Mitchel P. Goldman MD
Experimental Study: A comparison of the efficacy and safety of Augmentin 500/125 mg p.o. q12 hours and Augmentin 250/125 mg p.o. q8 hours in the treatment of uncomplicated skin and skin structure infections.
Jobst Institute, Inc. – Jun 1992
Principal Investigator: Mitchel P. Goldman MD
Clinical Study: Venous Insufficiency During Standing Occupation:Treatment with a 20-30 mm Hg Graduated Compression Stocking
Parke-Davis Pharmaceutical Research Division – Nov 1991
Co-Investigators: Mitchel P. Goldman MD, James Seltzer, MD
Clinical Phase III Study: Double-Blind, randomized, comparative, multicenter study of CI-983 versus cephalexin in the treatment of skin and skin structures.
Burroughs-Wellcome:Protocol #:P66-005 – Oct 1991
A Multicenter, Double-Blind, Controlled Trial Comparing Oral Acyclovir to Oral 256U87 for the Treatment of Herpes Zoster in Immunocompetent Patients 50 Years of Age and Older.
Burroughs-Wellcome:Protocol #:P66-006
A Multicenter, Double-Blind, Placebo-Controlled Trial Evaluating Oral 56U87 for the Treatment of Herpes Zoster in Immunocompetent Patients Less Than 50 Years Old
Candela Laser Corporation – Aug 1991
Principal Investigator: Co-Mitchel Goldman MD, Richard E. Fitzpatrick MD, Javier Ruiz Esparza MD
Clinical Study: Clinical & Histologic effects of the Alexandrite Laser on Various Tattoo Pigments
Candela Laser Corporation – Jul 1991
Principal Investigator: Co-Mitchel P. Goldman, MD, Richard E. Fitzpatrick MD, Javier Ruiz Esparza MD
Clinical Study: “”Treatment of Tattoos with Candela’s TL-1 Alexandrite Laser””
Janssen Research Foundation, Inc.-Medical Technical Research Associates, Inc. – Apr 1991
Clinical Study: Protocol JRD 41,400 – 3202.Double-Blind Multicenter Study of 2% Ketoconazole / 0.05% Desonide cream; 2% Ketoconazole cream; 0.05% Desonide cream & placebo cream in the treatment of inflammatory tinea cruris. (PhaseII; IND No. 31,783).
Co-Directors:J. Leonel Villavicencio MD, Mitchel Goldman MD, John Pheifer MD, John Cranley MD – Mar 1991
Clinical Phase II Study: Comparison of relative efficacy of polidocanol and sodium tetradecyl sulfate.FDA IND # 35139
Minnesota Clinical Study Center – Dec 1990
Clinical Study: Patient Study Group Participant. Lemmon Protocol #LC90-100.
Co-Directors: J. Leonel Villavicencio MD, Mitchel Goldman MD, John Pheifer MD, John Cranley MD
Palisades Pharmaceuticals, Inc. – Aug 1990
Experimental Study: Clinical and Histologic Examination of Sodium Morrhuate in the Dorsal Rabbit Ear Vein.
Candela Laser Corporation – Jan 1990
Co-Directors: Mitchel Goldman MD and Richard Fitzpatrick MD
Clinical Study: Efficacy of the Candela Pulse Dye Laser in the Treatment of Leg Telangiectasia with and without Simultaneous Sclerotherapy.
Candela Laser Corporation – Aug 1989
Director: Mitchel Goldman, MD
Experimental Study: Clinical and Histologic Examination of the Candela Pulse Dye Laser with and without Sclerotherapy in the Rabbit Ear Vein
Sandoz Pharmaceutical, San Diego Clinical Research Association, Inc.. – Mar 1989
Patient Study Group Participant
Clinical Study: Zaditen study # U-201
The Clinical Research Institute, Inc. – 4/88 – 7/89
Co-Directors: James Seltzer, MD, and Mitchel Goldman, MD
Clinical Study: Patch Test for Contact Dermatitis:Pharmacia True Test:Post-approval Clinical Study
Multicentered Clinical Study, American College of Phlebology – 11/86 – 2/89
Director: Mitchel P. Goldman, MD
Research Study: Microsclerotherapy of telangiectatic veins and superficial varicosities of the leg: A clinical study. Is compression necessary?
Experimental Study, Division of Dermatology, UCLA Medical Center – 6/85 – 11/85
Director: Richard Bennett, MD, Professor
Research Study: Sclerosis of the dorsal rabbit ear vein, a clinical and pathologic examination
Clinical Research, Division of Dermatology, UCLA Medical Center – 5/84 – 11/84
Director: Nicholas Lowe, MD, Professor
Research Study: Clinical Bilateral paired comparison efficacy study in eczema of a new non-steroidal agent (R-83OT) and 1% hydrocortisone
Technical Assistant, Cardiovascular Division, Department of Medicine Washington University – 9/77 – 6/78
Supervisor: Phillip Henry, MD, Professor
Research Study: Development of a rapid radioenzymatic assay for plasma catecholamines, and the study of adrenergic sensitivity of rabbit atherosclerotic arteries
Medical Research Technician, Department of Radiation Medicine – 1/77 – 6/77
Massachusetts General Hospital
Supervisor: Herman Suite, MD, Professor
Research Study: Immunotherapy on a variety of tumors in germ-free mice and humans, Immunotherapy induced stimulation of macrophages in vitro
Senior Distinction Work in Biology, Department of Biology, Boston University – 1/76 – 12/76
Supervisor: I.A. Macchi, PhD, Professor
Research Study: Characterization of the insulinotropic action of tolbutamide in pancreatic islets
Medical Research Technician, Department of Genetic Medicine – 6/75 – 9/75
University of Miami School of Medicine
Supervisor: Karl Muench, MD, Professor
Research Study: Isolation and sequencing of t-RNA tryptophan synthetase
Directed Study in Psychology, Boston University – 9/74 – 12/76
Supervisor: Margaret Hagen, Ph.D., Professor
Research Study: Three-dimensional depth perception/developmental perception of facial features.
